9th International Conference on Cerebral Vasospasm, İstanbul, Türkiye, 27 - 30 Haziran 2006, cilt.104, ss.291-293
Background. Vasospasm is still an important cause of morbidity and mortality following subarachnoid haemorrhage (SAH). The current study was, undertaken to determine whether cilostazol therapy reverses vasospasm.